SHFS Q3 2024 Earnings Positive EPS Emerges Amid Limited Disclosure BFRI Q1 2026 Earnings Wide EPS Miss Fails to Dampen Investor Sentiment Fate Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Pipeline Development GRAIL Q1 2026 Earnings EPS Beats Estimates as Losses Narrow OPCH Q1 2026 Earnings EPS Beat Amid Caution Stock Slips 191 Syndax Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Continues